Renal Cancer Information Center
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey? The Cancer Connect Renal Cancer Information Center has current, evidence-based information for you. Get the facts about renal cancer early detection, treatment, and survivorship, and stay up to date with ongoing renal cancer research that could impact your treatment decisions through our daily cancer news.
You are not alone—The CancerConnect Renal Cancer Community is the leading Social Media Application for Renal Cancer patients and caregivers seeking information, inspiration, and support in the wake of a cancer diagnosis. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs from diagnosis to survivorship. Login or register here.
LENVIMA is currently approved for the treatment of patients with radioactive iodine-refractory thyroid cancer. Study of Opdivo® versus Afinitor® Stopped Early when Opdivo Demonstrated Better Survival
All patients may continue treatment with Opdivo National Kidney Cancer Awareness Month on CancerConnect
As the month of March brings kidney cancer into focus, it’s time to increase public understanding of the disease
Cancer and its treatment can come with a variety of complications, some more serious... Advanced Directives
Living Wills Every competent adult has, in most cases, the freedom to accept or refuse... Caregivers
What is Caregiving and Who are Caregivers? Caregivers are individuals who provide...
Renal Cancer Management
Moving On Aerobics helps women regain joy of movement and physical fitness after... Where Kids Can Be Kids… And Cancer Takes a Back Seat
Cancer camps for kids provide fun and camaraderie for children facing down a cancer... Pay it Forward
Survivors become peer mentors to newly diagnosed women and offer experience, insight,...